Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-03	Matthew Young, Ph.D.
Huang, Ying	Western University Of Health Sciences United States	Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol	5R01CA269653-04	Anda Vlad, M.D., Ph.D.
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	5R01CA283687-02	Guillermo Marquez, Ph.D.
Huberty, Jennifer Lynne	University Of Texas Hlth Science Center United States	Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients	5R01CA262041-05	Marjorie Perloff, M.D.
Huh, Warner King	University Of Alabama At Birmingham United States	Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)	3R01CA279021-02S1	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hui, David	University Of Tx Md Anderson Can Ctr United States	Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology	5R01CA288515-02	Brennan Streck, Ph.D., RN, M.P.H.
Hundley, William Gregory	Wake Forest University Health Sciences United States	Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment	5R33CA226960-05	Eileen Dimond, R.N., M.S.
Hur, Chin	Columbia University Health Sciences United States	Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype	3R01CA257333-05S1	Matthew Young, Ph.D.
Hutson, Alan David	Roswell Park Cancer Institute Corp United States	Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center	1U24CA305623-01	Altaf Mohammed, Ph.D.
Huttenhower, Curtis	Broad Institute, Inc. United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297578-01S1	Asad Umar, D.V.M., Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-04	Matthew Young, Ph.D.
Im, Eun-Ok	University Of Texas At Austin United States	Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors	5R33CA280979-04	Brennan Streck, Ph.D., RN, M.P.H.
Infante, Rodney E	Ut Southwestern Medical Center United States	Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia	3R01CA266900-04S1	Marjorie Perloff, M.D.
Irvin, William J	Southeast Clinical Oncol Res Consortium United States	NCI Community Oncology Research Program 2025 Extension Request	3UG1CA189858-11S1	Vanessa A. White, M.P.H.
Iwelunmor, Juliet	Washington University United States	Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)	3U01CA279863-04S1	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.